产品详情
Targets
Target | Value |
---|---|
C-Raf | IC50: 1.4nM |
B-Raf | IC50: 8.3nM |
AuroraB | IC50: 66nM |
PDGFRβ | IC50: 120nM |
FGFR3 | IC50: 280nM |
GSK-3β | IC50: 500nM |
CDK2 | IC50: 580nM |
p38α | IC50: 600nM |
PDGFRα | IC50: 610nM |
Tie-2 | IC50: 740nM |
CDK1 | IC50: 790nM |
Chk1 | IC50: 1.4μM |
MEK1 | IC50: 3.7μM |
IKKβ | IC50: 3.7μM |
PKA | IC50: >10μM |
PKCθ | IC50: >10μM |
CK1δ | IC50: >10μM |
ERK1 | IC50: >10μM |
EGFR | IC50: >10μM |
HER2 | IC50: >10μM |
JNK1 | IC50: >10μM |
c-Met | IC50: >10μM |
c-Kit | IC50: >10μM |
Src | IC50: >10μM |
IR | IC50: >10μM |
MEKK1 | IC50: >10μM |
In vitro (25°C) | DMSO | 99 mg/mL (178.53 mM) | |
Water | Insoluble | ||
Ethanol | 2 mg/mL (3.6 mM) | ||
In vivo | 2% DMSO+98% PEG 300 | 4 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 18.03 mL | 90.17 mL | 180.34 mL |
0.5 mM | 3.61 mL | 18.03 mL | 36.07 mL |
1 mM | 1.8 mL | 9.02 mL | 18.03 mL |
5 mM | 0.36 mL | 1.8 mL | 3.61 mL |
*The above data is based on the productmolecular weight 554.51. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A13323 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 554.51 |
Formula | C27H18F4N4O3S |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 1228591-30-7 |
Synonyms | TAK 632; TAK632 |
SMILES | C1CC1C(=O)NC2=NC3=C(S2)C(=C(C=C3)OC4=CC(=C(C=C4)F)NC(=O)CC5=CC(=CC=C5)C(F)(F)F)C#N |
产品标签
Product Questions
Product Questions
PLX4032 (Vemurafenib)
PLX4032(Vemurafenib)也称为RG7204,Vemurafenib,R7204,RO5185426。PLX4032是B-raf抑制剂,IC50为44 nM。
Raf265 derivative
Raf265 derivative是Raf265的衍生物,Raf265是一种口服,高度选择性的RAF和VEGFR激酶抑制剂,IC50为5至10μM。
Regorafenib (BAY 73-4506)
Regorafenib (BAY 73-4506)是一种多激酶抑制剂,IC50为17、40和69 nM c-KIT,VEGFR2,B-Raf。Regorafenib(BAY 73-4506)是一种…
Balamapimod (MKI-833)
Balamapimod (MKI-833)是Ras/Raf/MEK抑制剂。
Dabigatran ethyl ester
Dabigatran ethyl ester是一种新兴的口服抗凝剂,是凝血酶活性的直接抑制剂。